Coeptis Therapeutics Holdings, Inc.
Ticker: 1759186
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|
| INCOME | |||||
| Revenue | 1.58+1336.4% | 0.11-54.2% | 0.24+20.0% | 0.20+233.3% | 0.06 |
| Total Income | 1.58+1336.4% | 0.11-54.2% | 0.24+20.0% | 0.20+233.3% | 0.06 |
| EXPENSES | |||||
| Expenditure | 15.38+281.6% | 4.03+48.7% | 2.71-42.6% | 4.72+14.6% | 4.12 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PROFIT | |||||
| PBT | -13.79-243.0% | -4.02-38.6% | -2.90+33.0% | -4.33-26.6% | -3.42 |
| Net Profit | -13.79-243.0% | -4.02-38.6% | -2.90+33.0% | -4.33-26.6% | -3.42 |
| KEY METRICS | |||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.28+56.9% | -0.65-12.1% | -0.58+50.4% | -1.17-5.4% | -1.11 |
Corporate Events
Board MeetingCOEP
20263Nov
Board Meeting
Jeffery Harris, Chief Technology Officer, elected as a direc…
SEC Filing ↗ Board MeetingCOEP
202624Jun
Board Meeting
Appointment of Jeffery Harris as Chief Technology Officer. …
SEC Filing ↗ Board MeetingCOEP
202622May
Board Meeting
Michelle Burke resigned as Co-Chief Executive Officer and di…
SEC Filing ↗